Fortune Rise Acquisition Corp. (FRLA) Sponsor Sells Interest to Water On Demand
by Marlena Haddad on 2022-12-29 at 5:31pm

Fortune Rise Acquisition Corp. (NASDAQ: FRLA) announced this afternoon that it has entered into a membership interest purchase and transfer agreement resulting in a change in leadership.

On December 22, FRLA’s sponsor, Fortune Rise Sponsor LLC, entered into a purchase agreement with water fintech startup Water On Demand, Inc. (WODI), Ka Wai Cheung, Koon Lin Chan, and Koon Keung Chan pursuant to which WODI purchased 100 membership interests in the sponsor, constituting 100% of the membership interests in the sponsor. The sponsor holds 2,343,750 shares out of 2,443,750 shares of the issued and outstanding shares of Class B Common Stock of Fortune Rise. The purchase price for the membership interests was $403,516.61.

As a result of the purchased interests, the officers and members of the Board of Directors of Fortune Rise tendered their resignations and WODI, as the holder of a majority of the Class B Common Stock, appointed Payam Eshraghian as the sole director and Chairman of the Board of Directors. He will also serve as a Member of the Audit Committee and a Member of the Compensation Committee.

Mr. Eshraghian, also known as Mr. Ian, is the Founder and President of Nerve, LLC, an insurtech and fintech software firm headquartered in California. He is also a strategic advisor for Agtools Inc., an AgriTech SaaS company mitigating risks across the global food supply chain.

Mr. Ian has appointed J. Richard Iler to serve as Fortune Rise’s Principal Executive Officer, CFO, Secretary, and Treasurer. Mr. Iler has spent his professional career in the capital markets working in various positions such as corporate finance, CFO of both public and private companies, and an institutional corporate bond salesman.

Additionally, Mr. Ian has appointed Ronald J. Pollack and Ryan Spick to serve as the company’s directors to fill vacancies left by outgoing directors.

Mr. Pollack is an experienced financial professional, angel investor and board member. He currently serves on the Board of Directors of Ronati and Venocare and the Advisory Board of CISO Global (NASDAQ: CISO). Mr. Pollack previously served on the Board of Directors of TiE Tampa and co-chair of its Florida angel network. Mr. Pollack was the Founder and Managing Partner of Bulldog Capital Management, a $1+ billion family of investment funds with a special focus on technology. He will also serve as Fortune Rise’s Chair of Audit Committee and a Member of the Compensation Committee.

Mr. Spick works with business owners to scale their companies through analysis and targeted improvements. His expertise ranges from determining target audience, market research, branding, developing budgets, estimates, scopes of work to client relations, as well as implementing back-office functions and coordinating with trades.  Mr. Spick will also serve as Fortune’s Chair of the Compensation Committee and a Member of the Audit Committee.

Fortune Rise announced its $85 million IPO in November 2021. The SPAC inked a $294 million deal with crypto mining business VCV Digital Technology in May 2022, but the business combination was terminated just two months after the announcement.

 

Recent Posts
by Nicholas Alan Clayton on 2023-11-20 at 7:41am

At the SPAC of Dawn Public companies of all stripes tend to bury news ahead of holidays and SPACs are no different. Four SPACs have announced their intent to liquidate since market close on Friday and three of these had previously agreed to business combinations. The last cluster of broken deals and liquidated SPACs this...

by Kristi Marvin on 2023-11-18 at 11:48am

Terms Tracker for the Week Ending November 17, 2023 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. SPACs saw another IPO this week from Global Lights Acquisition Corp. (Nasdaq: GLACU), the $60 million offering from Chardan, which had an impressive first day...

by Nicholas Alan Clayton on 2023-11-17 at 11:14am

Bellevue Life Sciences (NASDAQ:BLAC) has entered into a definitive agreement to combine with Korean healthcare holding company OSR for undisclosed compensation. Seoul-based OSR is a conglomerate of several biotech firms advancing drug candidates as well as a medical device distributor. Transaction Overview Bellevue has about $36.4 million in its current trust having seen 49.7% redeemed...

by Nicholas Alan Clayton on 2023-11-17 at 7:38am

At the SPAC of Dawn A largely positive week is coming to end with a summit that appears to have brought an autumn chill to simmering tensions between the US and China. Chinese President Xi Jinping and US President Joe Biden each offered olive branches and offhand “dictator” comments aside, both appeared to want to...

by Nicholas Alan Clayton on 2023-11-16 at 7:33am

At the SPAC of Dawn With the S&P 500 rolling into a two-month high on the back of positive inflation numbers, all hopes have to be for nothing too concerning coming out of a still-packed end of the week. Multiple Fed officials are set to give remarks throughout the next two days and the financial...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved